Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer

About this Study

This study compares the effects of hormone therapy (androgen deprivation) and  radiation therapy to the prostate gland and seminal vesicles with hormone therapy and  radiation therapy to the whole pelvic body area on participants and their prostate cancer to find out which is better.

Sponsor Protocol ID:RTOG 0924
IRB Number:2011-0175
Actively Enrolling
Phase 3
May 29, 2019
Eligibility Criteria
18 years old
Both Male and Female

Inclusion CriteriaNone

Exclusion CriteriaPatients who are sexually active and not willing/able to use medically acceptable forms of contraception

Categories Click category to view its trials.
Men's Health
Participating Locations
Cancer Center and Research Institute
University Hospital
Contact Information
Contact Name: Sandra Powe
Phone Number: 601-984-1965
Principal Investigator:Vijayakumar, Srinivasan, M.D.
How to participate in our Clinical Trials